Is Netskope HIPAA Compliant? What Healthcare Security Teams Should Ask in 2026

Short answer: yes, Netskope can be part of a HIPAA-compliant program. It will sign a Business Associate Agreement and it holds the certifications a healthcare buyer expects. But "can be configured for HIPAA" and "the cleanest way to protect PHI" are not the same sentence. Netskope steers traffic to its cloud for inspection, which means protected health information leaves the clinician's device and transits Netskope's infrastructure before it reaches its destination. dope.security inspects on the endpoint, so PHI never leaves the device to be examined. If your team is weighing the move, the fastest orientation is the complete guide to replacing Netskope.

Healthcare security teams ask "is Netskope HIPAA compliant" when they are really asking three deeper questions: will a vendor sign a BAA, will the architecture hold up to an auditor, and will it fit how clinicians actually work. The compliance checkbox is the easy part. The architecture is where the real decision lives.

Let us separate the paperwork from the plumbing, because in healthcare the plumbing is what an OCR investigator eventually asks about.

What HIPAA actually requires of a web gateway

HIPAA does not certify products. There is no "HIPAA compliant" stamp a gateway earns. The Security Rule requires covered entities and their business associates to protect electronic PHI with administrative, physical, and technical safeguards, and to sign Business Associate Agreements with vendors that handle that data.

For a secure web gateway, the relevant safeguards are access control, audit logging, transmission security, and minimizing where PHI travels. A vendor that inspects your traffic is, by definition, handling PHI in motion. That is exactly why the BAA exists, and exactly why the question of where inspection physically happens is not a technicality. It is the substance.

Yes, Netskope can be part of a HIPAA program

Credit where it is due. Netskope signs BAAs, maintains SOC 2 and other attestations, and offers DLP policies that can be tuned to detect PHI patterns. A healthcare organization can deploy Netskope, document the safeguards, and satisfy an auditor that controls are in place. Plenty of hospitals and clinics run it today.

So if the only question is "will this check the compliance box," the answer is yes. The harder question is what you trade to get there, and whether the architecture matches a workforce that no longer sits inside a hospital network. That is the same tension we unpack in our look at Netskope alternatives for healthcare.

The architecture question a BAA does not answer

A BAA is a legal promise about how a vendor will treat your data. It does not change where your data goes. With Netskope's tunnel-and-steer model, a clinician's traffic, PHI included, is routed to a Netskope point of presence, decrypted and inspected there, then forwarded on. The data is protected by contract, but it has still left the building and passed through a third party's cloud.

That introduces three things healthcare teams care about. It expands the footprint of systems that touch PHI, which expands what you have to account for in a breach analysis. It adds latency to the cloud apps clinicians use all day. And it ties protection to a steering configuration that has to be set up correctly per site, a setup burden we cover in why no-tunnel steering matters.

dope.security inspects PHI on the device itself. The proxy runs on the endpoint, SSL inspection happens locally, and traffic then flies direct to its destination. Protected data is examined where it already lives and never makes a detour through a vendor data center to be read.

What healthcare security teams should verify

If you are evaluating any gateway against a HIPAA program, run it against the requirements that actually move the needle, not the marketing.

The takeaway: both vendors can satisfy a HIPAA program on paper. They differ on where PHI physically goes to be inspected, and that difference is what an auditor and an incident responder will care about.

Where on-device inspection changes the PHI math

Think about a breach analysis. If PHI is inspected in a vendor cloud, that cloud is in scope: it is another place protected data lived, however briefly, and another system whose logs and controls you have to account for. If PHI is inspected on the device and never leaves to be read, the scope is smaller and the story is simpler. Fewer places PHI traveled means fewer places to investigate.

The same logic applies to data at rest. Exposed PHI sitting in an over-shared Google Drive or OneDrive file is a classic finding. dope.security's CASB Neural scans those drives for publicly or externally shared files containing PHI and offers one-click remediation, and it lives in the same console as the SWG. You are not stitching two products together to cover motion and rest. The distinction between endpoint and network data protection is worth understanding here, which we lay out in endpoint DLP vs network DLP.

The roaming clinician problem

Modern healthcare does not happen only inside a hospital. Home health nurses, traveling case managers, telehealth providers, and multi-site clinics put endpoints on cellular and home networks all day. A cloud proxy assumes there is a network egress to steer through. A clinician in a patient's living room on an LTE hotspot does not have one in the way the model expects, so protection depends on a tunnel staying up and configured.

On-device enforcement does not care about the network. Policy lives on the laptop, SSL inspection runs locally, and PHI is protected whether the clinician is on the hospital LAN, at home, or in a parking lot between visits. Outreach Health, a healthcare organization with 34 offices, replaced its legacy gateway with dope.security and secured 99% of devices within a week, with a 70% drop in web access tickets in 90 days. The cluster argument extends across vendors too, including Cisco Umbrella in healthcare.

BAA scope and the minimum-necessary principle

HIPAA's minimum-necessary standard is usually discussed in terms of who can see a patient record. It applies just as well to your infrastructure. Every system that touches PHI is a system you have to safeguard, document, and account for, and every Business Associate Agreement you sign is another relationship you have to manage and another party whose controls become part of your risk surface. The fewer places PHI travels, the smaller that surface gets.

This is the quiet argument for on-device inspection. When a cloud proxy inspects PHI, the vendor's cloud becomes a place protected data lived, so its certifications, its breach history, and its subprocessors all become relevant to your program. When inspection happens on the endpoint and PHI never leaves to be read, you have removed an entire tier from the chain. You still get the security outcome, deep inspection of data in motion, without adding a hop where PHI is decrypted in someone else's environment. For a compliance officer, that is a shorter list of things to defend.

It also simplifies the conversation with auditors. "PHI is inspected locally and never transits a third party for examination" is a cleaner sentence than "PHI is steered to our vendor's regional cloud, inspected there under a BAA, and forwarded." Both can be compliant. Only one of them shrinks the footprint you are responsible for.

Speed matters in clinical settings too

There is a patient-care angle that often gets lost in compliance reviews. Clinicians work in electronic health record systems, imaging portals, and telehealth platforms all day, and every one of those is a cloud app. Routing that traffic to a proxy point of presence and back adds latency to tools people use between patient visits, and slow tools get worked around. An on-device gateway inspects locally and lets traffic fly direct, so the security control does not tax the clinical workflow it is meant to protect. Protection that clinicians do not fight is protection that actually stays on.

Netskope and HIPAA: quick answers

Is Netskope HIPAA compliant? Netskope can support a HIPAA-compliant program. It signs a BAA and holds relevant attestations. HIPAA does not certify products, so no gateway is "HIPAA compliant" on its own. The compliance comes from how you deploy and document it.

Does Netskope sign a Business Associate Agreement? Yes. Any vendor inspecting PHI in motion needs one, and Netskope provides it.

Why consider an alternative if Netskope can be HIPAA compliant? Because compliance and architecture are different decisions. Netskope inspects PHI in its cloud after steering. dope.security inspects on the device, so PHI never leaves the endpoint to be read, which is a cleaner data-residency and breach-scope posture for healthcare.

What is the best web gateway for home health and telehealth? One that enforces policy on the device without depending on a tunnel, since clinicians work on cellular and home networks. dope.security runs on the endpoint and protects PHI on or off any network.

Compliance is the floor, not the finish line

Netskope clears the HIPAA bar, and any honest evaluation should say so. But clearing the bar is not the same as choosing the architecture that keeps protected data closest to home. Netskope reads PHI in its cloud after routing it there. dope.security reads it on the device and lets it fly direct, so the protected data your program exists to safeguard never takes a detour through someone else's infrastructure to be inspected. For healthcare teams, that smaller footprint is the difference worth weighing, and the complete guide to replacing Netskope is where to start. You can also see the on-device DLP and cloud scanning directly via dope.SWG and CASB Neural.

Try it free on your own clinician devices at dope.security/pricing, or book a 20-minute demo.